| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964182 | Vaccine | 2015 | 7 Pages |
Abstract
From both perspectives, introducing the rotavirus vaccine is highly cost-effective compared to no vaccination. The results are consistent with those found in many African countries. The ProVac process and tools contributed to a collaborative, country-led process in Senegal that provides a platform for gathering and reporting evidence for vaccine decision-making.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Abdou Diop, Deborah Atherly, Alioune Faye, Farba Lamine Sall, Andrew D. Clark, Leon Nadiel, Binetou Yade, Mamadou Ndiaye, Moussa Fafa Cissé, Mamadou Ba,